SL-1002

DRUG2 trials

Sponsors

Saol Therapeutics Inc

Conditions

Osteoarthritis, Knee PainSpasticity

Phase 2

Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity

Saol Therapeutics IncSpasticity

Start: 2022-04-22End: 2023-09-30Target: 32Updated: 2023-09-06

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

Saol Therapeutics IncOsteoarthritis, Knee Pain

Start: 2022-06-13End: 2024-01-31Target: 132Updated: 2023-08-29